Autism spectrum disorder: strengthening screening for optimal outcomes The Lancet Regional Health – Southeast Asia + + +...

Low-dose nivolumab with neoadjuvant chemotherapy and oral metronomic therapy in borderline resectable oral cavity squamous cell carcinoma: a phase II trial Praveen Kumar Marimuthua Drmpk91@gmail.com ∙ Chitra Renukaradhyab chitraardhya@gmail.com ∙ Shalini Sahuc sahushalini07@gmail.com ∙ Ajoy Oommen Johna ajoyoommenjohn@gmail.com ∙ Amit Jiwan Tirkeyd jiwan@cmcvellore.ac.in ∙ Balu Krishna Sasidharane balunair@cmcvellore.ac.in ∙ et al. https://www.thelancet.com/journals/lansea/article/PIIS2772-3682(26)00028-4/fulltext?dgcid=raven_jbs_etoc_feature_lansea Autism spectrum disorder: strengthening screening for optimal outcomes The Lancet Regional Health – Southeast Asia https://www.thelancet.com/journals/lansea/article/PIIS2772-3682(26)00056-9/fulltext?dgcid=raven_jbs_etoc_email Apr 2026 Volume 47 https://www.thelancet.com/journals/lansea/issue/vol47nonull/PIIS2772-3682(26)X2002-9